ED
CAH icon

Exane Derivatives’s Cardinal Health CAH Stock Holding History

Exane Derivatives’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$418 Sell
8
-1
-11% -$57 ﹤0.01% 593
2022
Q1 		$510 Sell
9
-1,401
-99% -$75K ﹤0.01% 857
2021
Q4 		$72.6K Buy
1,410
+1,381
+4,762% +$67.7K 0.02% 465
2021
Q3 		$1.43K Hold
29
– – ﹤0.01% 826
2021
Q2 		$1.66K Hold
29
– – ﹤0.01% 829
2021
Q1 		$1.76K Hold
29
– – ﹤0.01% 691
2020
Q4 		$1.55K Sell
29
-21,237
-100% -$1.1M ﹤0.01% 647
2020
Q3 		$998K Buy
21,266
+19,812
+1,363% +$1.02M 0.29% 83
2020
Q2 		$75.9K Sell
1,454
-46,590
-97% -$2.4M 0.02% 323
2020
Q1 		$2.3M Sell
48,044
-24,512
-34% -$1.27M 0.64% 36
2019
Q4 		$3.9M Sell
72,556
-5,487
-7% -$283K 0.72% 35
2019
Q3 		$3.68M Buy
78,043
+72,326
+1,265% +$3.3M 0.66% 34
2019
Q2 		$269K Sell
5,717
-72,912
-93% -$3.36M 0.05% 231
2019
Q1 		$3.78M Buy
78,629
+9,632
+14% +$483K 0.75% 38
2018
Q4 		$3.08M Buy
68,997
+65,648
+1,960% +$3.42M 0.55% 56
2018
Q3 		$180K Sell
3,349
-3,040
-48% -$156K 0.03% 257
2018
Q2 		$317K Buy
6,389
+4,355
+214% +$247K 0.05% 206
2018
Q1 		$126K Sell
2,034
-11,352
-85% -$779K 0.03% 276
2017
Q4 		$820K Buy
13,386
+12,455
+1,338% +$770K 0.14% 119
2017
Q3 		$62.3K Sell
931
-261
-22% -$18.4K 0.01% 290
2017
Q2 		$92.9K Sell
1,192
-181
-13% -$13.7K 0.02% 277
2017
Q1 		$112K Sell
1,373
-1,200
-47% -$94.5K 0.03% 222
2016
Q4 		$185K Sell
2,573
-275
-10% -$19.9K 0.04% 205
2016
Q3 		$221K Sell
2,848
-584
-17% -$47.2K 0.03% 199
2016
Q2 		$268K Sell
3,432
-323
-9% -$25.8K 0.04% 183
2016
Q1 		$308K Sell
3,755
-202,216
-98% -$16.4M 0.04% 167
2015
Q4 		$18.4M Buy
205,971
+203,097
+7,067% +$17.2M 2.52% 8
2015
Q3 		$221K Buy
2,874
+2,872
+143,600% +$240K 0.03% 178
2015
Q2 		$167 Hold
2
– – ﹤0.01% 476
2015
Q1 		$181 Sell
2
-154,128
-100% -$13.3M ﹤0.01% 478
2014
Q4 		$12.4M Buy
+154,130
New +$12.2M 1.72% 30

Other funds holding CAH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Exane Derivatives's CAH Position: Q2 2022 in Review

Exane Derivatives reduced its Cardinal Health (CAH) stake by 11% in Q2 2022, selling an estimated $57 and leaving 8 shares worth $418. The position accounts for ﹤0.01% of the portfolio, ranked #593.

Exane Derivatives first reported a position in CAH in Q4 2014 and has held it in 31 quarters since. The position peaked at $18.4M in Q4 2015. 793 funds tracked by Wall St. Rank hold CAH as of Q2 2022.

  • Exane Derivatives held 8 shares of Cardinal Health worth $418 as of Q2 2022.
  • Exane Derivatives sold 1 Cardinal Health share in Q2 2022, an estimated $57.
  • Cardinal Health made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #593 holding.
  • Exane Derivatives first reported a position in Cardinal Health in Q4 2014 and has held it in 31 quarters since.
  • Exane Derivatives's Cardinal Health position peaked at $18.4M in Q4 2015.
  • 793 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.